503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.13%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-11.13%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-3.01%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
1.18%
Similar margin change to CRWV's 1.30%. Walter Schloss would investigate industry pricing power.
-10.41%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.91%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-20.59%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-17.02%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
35.36%
Similar EBITDA growth to CRWV's 33.05%. Walter Schloss would investigate industry trends.
64.92%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
35.36%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
41.20%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
-41.97%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
17.90%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
22.98%
Similar pre-tax margin growth to CRWV's 26.86%. Walter Schloss would investigate industry trends.
776.40%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
-15.11%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-11.45%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-14.71%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-14.71%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.49%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.46%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.